Dr. Julie Grenier joined Certara in March 2018 as an Associate Director, supporting an integrated drug development approach for our client base. Julie has almost 20 years of drug development experience with a focus in pharmacokinetics, pharmacodynamics and clinical pharmacology study design, analysis and interpretation. Before joining Certara, Julie was an Associate Director of Clinical Pharmacology at Celerion, where Julie lead a multidisciplinary team of scientists focused predominantly on drug-drug interaction, bioavailability and bioequivalence, first-in-human, hepatic and renal impairment, human mass balance, and cardiac liability assessments. Throughout the years, Julie has overseen dozens of studies from protocol development to final clinical study report. Additionally, Julie has experience in pharmacometrics and earned her PhD in modeling and simulation (Pharmaceutical Science) from University of Montreal.